ZA91525B - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- ZA91525B ZA91525B ZA91525A ZA91525A ZA91525B ZA 91525 B ZA91525 B ZA 91525B ZA 91525 A ZA91525 A ZA 91525A ZA 91525 A ZA91525 A ZA 91525A ZA 91525 B ZA91525 B ZA 91525B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909001886A GB9001886D0 (en) | 1990-01-26 | 1990-01-26 | Pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA91525B true ZA91525B (en) | 1992-02-26 |
Family
ID=10669997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA91525A ZA91525B (en) | 1990-01-26 | 1991-01-24 | Pharmaceutical formulation |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0511991B1 (fi) |
| JP (1) | JP2545317B2 (fi) |
| KR (1) | KR0170414B1 (fi) |
| CN (1) | CN1056058C (fi) |
| AP (1) | AP197A (fi) |
| AT (1) | ATE142880T1 (fi) |
| AU (1) | AU643975B2 (fi) |
| CA (1) | CA2074503C (fi) |
| CY (2) | CY1984A (fi) |
| DE (1) | DE69122229T2 (fi) |
| DK (1) | DK0511991T3 (fi) |
| ES (1) | ES2092559T3 (fi) |
| FI (1) | FI101600B (fi) |
| GB (1) | GB9001886D0 (fi) |
| GR (1) | GR3021385T3 (fi) |
| HK (1) | HK218996A (fi) |
| HU (1) | HU215842B (fi) |
| IE (1) | IE910249A1 (fi) |
| IL (1) | IL97008A (fi) |
| LU (1) | LU90110I2 (fi) |
| MA (1) | MA22051A1 (fi) |
| MY (1) | MY110074A (fi) |
| PL (1) | PL166678B1 (fi) |
| PT (1) | PT96563B (fi) |
| SA (1) | SA91110341B1 (fi) |
| SG (1) | SG49144A1 (fi) |
| TW (1) | TW307687B (fi) |
| WO (1) | WO1991011187A1 (fi) |
| ZA (1) | ZA91525B (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9114939D0 (en) * | 1991-07-11 | 1991-08-28 | Smithkline Beecham Plc | Pharmaceutical formulation |
| US6124304A (en) * | 1993-10-05 | 2000-09-26 | Smithkline Beecham Plc | Penciclovir for the treatment of zoster associated pain |
| GB9326177D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9601544D0 (en) * | 1996-01-26 | 1996-03-27 | Smithkline Beecham Plc | Pharmaceuticals |
| US7223387B2 (en) | 1998-11-18 | 2007-05-29 | Medivir Ab | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| WO2017029298A1 (en) | 2015-08-17 | 2017-02-23 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A topical antiviral composition |
| EP3775116A4 (en) * | 2018-04-05 | 2022-03-23 | Bausch Health Ireland Limited | POLYMER EMULSION DISTRIBUTION SYSTEMS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1523865A (en) * | 1974-09-02 | 1978-09-06 | Wellcome Found | Purine compunds and salts thereof |
| GB2080106B (en) * | 1980-07-18 | 1984-03-07 | Weelcome Foundation Ltd | Acyclovin preparations |
| KR830005852A (ko) * | 1980-07-18 | 1983-09-14 | 미첼 페터 잭슨 | 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법 |
| EP0095813A3 (en) * | 1982-06-01 | 1985-05-08 | THE PROCTER & GAMBLE COMPANY | Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine |
| EP0141927B1 (en) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Antiviral guanine derivatives |
| IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
| DE3571810D1 (en) * | 1984-01-26 | 1989-08-31 | Merck & Co Inc | Substituted butyl guanines and their utilization in antiviral compositions |
| DE3671227D1 (de) * | 1985-07-27 | 1990-06-21 | Beecham Group Plc | 9-substituierte guaninmonohydrate. |
-
1990
- 1990-01-26 GB GB909001886A patent/GB9001886D0/en active Pending
-
1991
- 1991-01-22 MY MYPI91000108A patent/MY110074A/en unknown
- 1991-01-23 IL IL9700891A patent/IL97008A/en active IP Right Review Request
- 1991-01-24 MA MA22324A patent/MA22051A1/fr unknown
- 1991-01-24 JP JP3502630A patent/JP2545317B2/ja not_active Expired - Lifetime
- 1991-01-24 ZA ZA91525A patent/ZA91525B/xx unknown
- 1991-01-24 DE DE69122229T patent/DE69122229T2/de not_active Expired - Lifetime
- 1991-01-24 CA CA002074503A patent/CA2074503C/en not_active Expired - Lifetime
- 1991-01-24 EP EP91902429A patent/EP0511991B1/en not_active Expired - Lifetime
- 1991-01-24 WO PCT/GB1991/000102 patent/WO1991011187A1/en active IP Right Grant
- 1991-01-24 PL PL91295865A patent/PL166678B1/pl unknown
- 1991-01-24 PT PT96563A patent/PT96563B/pt not_active IP Right Cessation
- 1991-01-24 SG SG1996006831A patent/SG49144A1/en unknown
- 1991-01-24 AT AT91902429T patent/ATE142880T1/de active
- 1991-01-24 ES ES91902429T patent/ES2092559T3/es not_active Expired - Lifetime
- 1991-01-24 AU AU71558/91A patent/AU643975B2/en not_active Expired
- 1991-01-24 KR KR1019920701762A patent/KR0170414B1/ko not_active IP Right Cessation
- 1991-01-24 DK DK91902429.9T patent/DK0511991T3/da active
- 1991-01-24 IE IE024991A patent/IE910249A1/en not_active IP Right Cessation
- 1991-01-24 HU HU9202431A patent/HU215842B/hu unknown
- 1991-01-25 AP APAP/P/1991/000236A patent/AP197A/en active
- 1991-01-26 CN CN91100547A patent/CN1056058C/zh not_active Expired - Lifetime
- 1991-03-12 TW TW080101931A patent/TW307687B/zh active
- 1991-05-07 SA SA91110341A patent/SA91110341B1/ar unknown
-
1992
- 1992-07-24 FI FI923371A patent/FI101600B/fi active Protection Beyond IP Right Term
-
1996
- 1996-10-16 GR GR960402759T patent/GR3021385T3/el unknown
- 1996-12-24 HK HK218996A patent/HK218996A/xx not_active IP Right Cessation
-
1997
- 1997-07-23 LU LU90110C patent/LU90110I2/fr unknown
- 1997-09-05 CY CY198497A patent/CY1984A/xx unknown
-
1999
- 1999-09-30 CY CY199900020C patent/CY1999020I2/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL102777A0 (en) | Pharmaceutical combination formulation | |
| GB9114950D0 (en) | Pharmaceutical formulation | |
| GB9001886D0 (en) | Pharmaceutical formulation | |
| GB8917959D0 (en) | Pharmaceutical formulation | |
| GB9216061D0 (en) | Pharmaceutical combination formulation | |
| GB9000241D0 (en) | Pharmaceutical use | |
| IE901206L (en) | Pharmaceutical formulation | |
| GB9006650D0 (en) | Pharmaceutical formulation | |
| IE900901L (en) | Pharmaceutical formulation | |
| GB9022280D0 (en) | Pharmaceutical formulation | |
| GB9013312D0 (en) | Pharmaceutical formulation | |
| GB9019070D0 (en) | Pharmaceutical formulation | |
| ZA915450B (en) | Pharmaceutical composition | |
| GB9121798D0 (en) | Pharmaceutical formulation | |
| GB9122114D0 (en) | Pharmaceutical formulation | |
| GB9122115D0 (en) | Pharmaceutical formulation | |
| GB9112974D0 (en) | Pharmaceutical formulation | |
| GB9116467D0 (en) | Pharmaceutical formulation | |
| ZA915026B (en) | Pharmaceutical formulations | |
| GB9221694D0 (en) | Pharmaceutical formulation | |
| GB9212968D0 (en) | Pharmaceutical formulation | |
| GB8909924D0 (en) | Pharmaceutical formulation | |
| GB8919594D0 (en) | Pharmaceutical formulation | |
| GB8919596D0 (en) | Pharmaceutical formulation | |
| GB8923046D0 (en) | Pharmaceutical formulation |